Fundraising FoxACatechol
Santa Barbara, US · Founded 2016 · Delaware corporation
Find your way into ACatechol
Sign up to see every warm intro you have to ACatechol
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ACatechol team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.
Founders & leadership
ACatechol was founded in 2016 by Kollbe Ando Ahn.
Board
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2016
▶$400KraisedFeb 2016 · 2 investors · Other TechnologyRule 506(b)
- Jin-Soo AhnExecutive Officer, Director
- Eric Cook RyanDirector
- Byung-Jun AhnExecutive Officer, Director
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $273.5K |
| National Science Foundation | Phase I | 2020 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does ACatechol do?
- ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.
- Who founded ACatechol?
- ACatechol was founded by Kollbe Ando Ahn in 2016.
- How much funding has ACatechol raised?
- ACatechol has disclosed $400K raised across 1 round.
- Where is ACatechol headquartered?
- ACatechol is headquartered in Santa Barbara, US.